439 related articles for article (PubMed ID: 25716136)
1. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis.
Jacob C; Bechtel B; Engel S; Kardos P; Linder R; Braun S; Greiner W
Eur J Health Econ; 2016 Mar; 17(2):195-201. PubMed ID: 25716136
[TBL] [Abstract][Full Text] [Related]
2. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
Park CS; Kang HY; Kwon I; Kang DR; Jung HY
J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
[TBL] [Abstract][Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
7. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
[TBL] [Abstract][Full Text] [Related]
8. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
10. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
Lage MJ; Gross GN; Brewster C; Spalitto A
Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
[TBL] [Abstract][Full Text] [Related]
12. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.
Black J; Reaven NL; Funk SE; McGaughey K; Ohayon M; Guilleminault C; Ruoff C; Mignot E
Sleep Med; 2014 May; 15(5):522-9. PubMed ID: 24768358
[TBL] [Abstract][Full Text] [Related]
13. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio.
Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG
J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971
[TBL] [Abstract][Full Text] [Related]
14. The impact of CHIP coverage on children with asthma in Alabama.
Menachemi N; Blackburn J; Sen B; Morrisey MA; Becker DJ; Caldwell C; Kilgore ML
Clin Pediatr (Phila); 2012 Mar; 51(3):247-53. PubMed ID: 21890839
[TBL] [Abstract][Full Text] [Related]
15. Societal burden of cluster headache in the United States: a descriptive economic analysis.
Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
[TBL] [Abstract][Full Text] [Related]
16. Out-of-pocket medication costs and use of medications and health care services among children with asthma.
Karaca-Mandic P; Jena AB; Joyce GF; Goldman DP
JAMA; 2012 Mar; 307(12):1284-91. PubMed ID: 22453569
[TBL] [Abstract][Full Text] [Related]
17. The economic impact of children dispensed asthma medications without an asthma diagnosis.
Stempel DA; Spahn JD; Stanford RH; Rosenzweig JR; McLaughlin TP
J Pediatr; 2006 Jun; 148(6):819-23. PubMed ID: 16769395
[TBL] [Abstract][Full Text] [Related]
18. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals.
Kim SH; Kim TW; Kwon JW; Kang HR; Lee YW; Kim TB; Kim SH; Park HW; Park SW; Chang YS; Cho YS; Park JW; Cho YJ; Yoon HJ; Cho SH; Choi BW; Moon HB; Min KU
J Asthma; 2012 Apr; 49(3):303-9. PubMed ID: 22185405
[TBL] [Abstract][Full Text] [Related]
19. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population.
Colice G; Wu EQ; Birnbaum H; Daher M; Marynchenko MB; Varghese S
J Occup Environ Med; 2006 Aug; 48(8):794-802. PubMed ID: 16902372
[TBL] [Abstract][Full Text] [Related]
20. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
